Latest news with #DrugControlAdministration
Time of India
4 days ago
- Time of India
Empowered by SC verdict, DCA nabs two drug distributors for selling counterfeit cholesterol medicines
Hyderabad: Officials of the Telangana unit of the Drug Control Administration (DCA) recently busted a major spurious drug racket by arresting two wholesale drug distributors from Koti for allegedly selling counterfeit cholesterol drugs falsely labelled as those of a leading pharma brand. The move is being hailed as the first of its kind in the state, as it is for the first time that DCA officials arrested the accused, produced them in court and secured judicial remand of two weeks in order to question them and gather more details about their racket. The DCA inspectors conducted an extensive operations starting from seizure of drugs to medical tests, and arrests of the accused individuals and subsequent legal procedures such as legal paperwork, courtroom arguments and jail handover. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad The DCA's newfound authority comes from a 2020 Supreme Court order where it stated that the drug inspectors have the power to arrest individuals for offences under the Drugs and Cosmetics Act, particularly concerning spurious drugs, without a warrant. "Our action is now being seen as a precedent, with DCAs in other states also planning to make arrests in similar cases. The arrests were necessary as there is a risk of the accused tampering with the evidence. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo Our teams will travel to Delhi to investigate the source of these spurious drugs," another official said. The counterfeit medicines, Rosuvas F20 and Rosuvas F10, were recently put on a list of spurious drugs by India's drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO). The arrested individuals, identified as Praveen Kumar Kanodia of Ganga Pharma Distributors and Mithinti Srinivas of Sri Nandini Pharma, were allegedly distributing spurious batches of Rosuvas F20 and Rosuvas F10. The duo was subsequently remanded to 14 days of judicial custody. The spurious drugs, which claimed to lower cholesterol levels, were reportedly falsely labelled as products of Sun Pharmaceutical Industries Ltd, a leading pharma brand. "Distributing counterfeit or duplicate medicines is a cognisable offence, and arrests can be made in such cases with the court having to send the accused to remand. To check that the drug is spurious, we confirmed with the original manufacturer and even conducted our own tests. We even explained the same to the magistrate in Nampally, and that is a serious matter of public health. Pharma companies lose billions due to these parallel counterfeit networks," said a DCA drug inspector. Since the two arrests in late June in Hyderabad, DCA officials have arrested two more persons — one in Karimnagar and another in Hyderabad — in connection with an anti-epileptic drug, again fraudulently bearing Sun Pharma's label. Shahnawaz Qasim, director general, DCA Telangana, said, "We have adopted a zero-tolerance policy and will not allow Telangana to become a hub of spurious drugs. We will be increasing our crackdown in the coming days. Administrative action will be taken against those accused, including suspension of licence." Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Business Upturn
31-07-2025
- Business
- Business Upturn
MedPlus Health arm receives drug license suspension orders for Telangana stores
By Aditya Bhagchandani Published on July 31, 2025, 19:03 IST MedPlus Health Services Limited has informed exchanges that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders pertaining to drug licenses for its retail outlets in Telangana. According to the regulatory filing dated July 31, 2025, the Drug Control Administration, Warangal, issued the following suspension orders: Store at Station Ghanpur : License suspended for five days : License suspended for Store at Girinigadda Main Road, Jangaon: License suspended for three days These actions were taken under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The orders were received on July 30, 2025. Financial Impact The suspension is expected to result in: An estimated revenue loss of ₹0.98 lakh from the Station Ghanpur store from the Station Ghanpur store A ₹0.40 lakh loss from the Girinigadda store The company clarified that while the impact is minimal and localized, it is fully cooperating with the authorities to comply with all regulatory directives. The announcement has been made public in compliance with SEBI disclosure norms and is available on the MedPlus website and stock exchange portals. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
The Hindu
07-05-2025
- Health
- The Hindu
DCA seize ayurvedic drugs worth ₹44.40 lakh
The Drug Control Administration (DCA) conducted surprise inspection at a private ayurvedic hospital-cum-drug store located at Moghalrajpuram in Vijayawada on Wednesday and seized drugs worth about ₹44.40 lakh. The team led by Assistant Director K. Anil Kumar and Drugs Inspector J. Vinodh (Zone-I) seized stocks which were found to have objectionable therapeutic claims on its labels. The stock had objectionable labels, such as treatment for fever, tuberculosis, asthma, reduction of cancer cells, stimulation of the nervous system and brain, and promotion of vitality, thereby contravening the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, said Drugs Inspector (Zone-II) P. Sri Rama Murthy in a release.
